Review article
Fluconazole prophylaxis in preterm infants: a systematic review

https://doi.org/10.1016/j.bjid.2017.01.008Get rights and content
Under a Creative Commons license
open access

Abstract

Objective

This article aims to review the use of antifungal prophylaxis with intravenous fluconazole in premature newborns and the occurrence of Invasive Candidiasis.

Methods

This is a systematic review with search at databases: PubMed, Capes Portal, Virtual Health Library (BVS – Biblioteca Virtual em Saúde)/Lilacs, Scopus and Cochrane. The keywords used were: “Antifungal”, “Candida” “Fluconazole prophylaxis” and “Preterm infants”.

Results

Invasive Candidiasis was evaluated in all the twelve items. In eleven of them, there was a statistically significant difference between the groups receiving prophylactic fluconazole, with lower frequency of Invasive Candidiasis, compared to placebo or no prophylaxis group. Colonization by Candida species was also evaluated in five studies; four of them presented statistically lower proportion of colonization in patients with Fluconazole prophylaxis, compared to placebo or no drugs. In one study, there was a significant difference, favoring the use of fluconazole, and reduction of death.

Conclusion

Studies indicate the effectiveness of prophylaxis with fluconazole, with reduction in the incidence of colonization and invasive fungal disease. The benefits of prophylaxis should be evaluated considering the incidence of candidiasis in the unit, the mortality associated with candidiasis, the safety and toxicity of short and long-term medication, and the potential for development of resistant pathogens.

Keywords

Antifungal
Candida
Fluconazole prophylaxis
Preterm infants

Cited by (0)